Indication
BREXAFEMME® is a triterpenoid antifungal indicated for the treatment of adult and postmenarchal pediatric females with vulvovaginal candidiasis (VVC).
Meet BREXAFEMME:
The first and only oral fungicidal treatment for vaginal yeast infections1,2

BREXAFEMME provides rapid relief of burning, itching, and irritation with complete clinical cure in a one-day, oral dose1,2
Meet BREXAFEMME:
The first and only oral fungicidal treatment for vaginal yeast infections1,2
BREXAFEMME provides rapid relief of burning, itching, and irritation with complete clinical cure in a one-day, oral dose1,2

Broad-spectrum activity,*
including fluconazole-resistant,
non-albicans species, such as
Candida glabrata1,2
*Based on in vitro studies. Clinical significance is unknown.1
MoA=mechanism of action.